Finward Bancorp acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 32,575 shares of the pharmacy operator's stock, valued at approximately $304,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its stake in shares of Walgreens Boots Alliance by 193.4% in the third quarter. Wellington Management Group LLP now owns 193,526 shares of the pharmacy operator's stock worth $1,734,000 after acquiring an additional 127,558 shares during the last quarter. TD Private Client Wealth LLC increased its position in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after purchasing an additional 3,208 shares during the last quarter. Virtu Financial LLC purchased a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth about $208,000. Westside Investment Management Inc. grew its stake in shares of Walgreens Boots Alliance by 14.3% in the 3rd quarter. Westside Investment Management Inc. now owns 11,587 shares of the pharmacy operator's stock valued at $104,000 after buying an additional 1,454 shares in the last quarter. Finally, Wealthquest Corp acquired a new position in Walgreens Boots Alliance in the third quarter worth approximately $130,000. 58.59% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the stock. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Bank of America raised their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. Finally, StockNews.com assumed coverage on Walgreens Boots Alliance in a report on Saturday. They set a "hold" rating on the stock. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $10.59.
Read Our Latest Research Report on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Performance
NASDAQ WBA traded up $0.09 during midday trading on Friday, hitting $10.89. The company had a trading volume of 7,857,996 shares, compared to its average volume of 21,038,098. The firm has a fifty day simple moving average of $10.85 and a two-hundred day simple moving average of $10.13. The stock has a market cap of $9.42 billion, a price-to-earnings ratio of -1.06, a P/E/G ratio of 1.31 and a beta of 0.67. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.83.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company's quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the company earned $1.20 EPS. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
About Walgreens Boots Alliance
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Further Reading
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
